BioCentury | Apr 18, 2020
Finance

April 17 Quick Takes: Mabworks’ $160M series C; plus RDMD, PIC, SIRS, Atomo and Lantern

...Beijing antibody play Mabworks raises $160M Mabworks Biotech Co. Ltd. raised RMB1.1 billion ($160 million) in series C1 and...
...Targets eIF4E - Eukaryotic translation initiation factor 4E Elizabeth S. Eaton and Hongjiang Li, Staff Writers Wellington Partners Mabworks Biotech Co. Ltd. Lantern...
BioCentury | Sep 6, 2018
Finance

Jacobio’s ladder

...Details regarding the start-ups’ pipelines and financing histories are not disclosed. Last year, Jacobio and Mabworks Biotech Co. Ltd....
BioCentury | Jan 27, 2017
Financial News

Mabworks raises RMB270M round

...begin a Phase I trial this year of innovative candidate MIL62 to treat non-Hodgkin's lymphoma. Becky Simon Mabworks Biotech Co. Ltd....
BioCentury | Mar 31, 2016
Product R&D

Stalking Ebola

...of Manitoba, the Public Health Agency of Canada, the Institute of Basic Medical Sciences and Mabworks Biotech Co. Ltd....
...Inc., Toronto, Ontario Humabs BioMed S.A., Bellinzona, Switzerland Institute of Basic Medical Sciences, Beijing, China Mabworks Biotech Co. Ltd....
...Medicine , Mapp Bio and the Public Health Agency of Canada (PHAC) teamed up with Mabworks Biotech Co. Ltd....
BioCentury | May 4, 2009
Emerging Company Profile

Corporate Profile

...and Renfeng Guo University collaborators: Friedrich Schiller University and University of Michigan Corporate partners: Beijing Mabworks Biotech Co. Ltd....
Items per page:
1 - 5 of 5
BioCentury | Apr 18, 2020
Finance

April 17 Quick Takes: Mabworks’ $160M series C; plus RDMD, PIC, SIRS, Atomo and Lantern

...Beijing antibody play Mabworks raises $160M Mabworks Biotech Co. Ltd. raised RMB1.1 billion ($160 million) in series C1 and...
...Targets eIF4E - Eukaryotic translation initiation factor 4E Elizabeth S. Eaton and Hongjiang Li, Staff Writers Wellington Partners Mabworks Biotech Co. Ltd. Lantern...
BioCentury | Sep 6, 2018
Finance

Jacobio’s ladder

...Details regarding the start-ups’ pipelines and financing histories are not disclosed. Last year, Jacobio and Mabworks Biotech Co. Ltd....
BioCentury | Jan 27, 2017
Financial News

Mabworks raises RMB270M round

...begin a Phase I trial this year of innovative candidate MIL62 to treat non-Hodgkin's lymphoma. Becky Simon Mabworks Biotech Co. Ltd....
BioCentury | Mar 31, 2016
Product R&D

Stalking Ebola

...of Manitoba, the Public Health Agency of Canada, the Institute of Basic Medical Sciences and Mabworks Biotech Co. Ltd....
...Inc., Toronto, Ontario Humabs BioMed S.A., Bellinzona, Switzerland Institute of Basic Medical Sciences, Beijing, China Mabworks Biotech Co. Ltd....
...Medicine , Mapp Bio and the Public Health Agency of Canada (PHAC) teamed up with Mabworks Biotech Co. Ltd....
BioCentury | May 4, 2009
Emerging Company Profile

Corporate Profile

...and Renfeng Guo University collaborators: Friedrich Schiller University and University of Michigan Corporate partners: Beijing Mabworks Biotech Co. Ltd....
Items per page:
1 - 5 of 5